A sizeable population of Ag85A−, TB10.4−, and RpfB-specific CD8+IFNγ+ T cells still remained in the LPT 6 weeks post-Tri:ChAd:TB immunization (Fig. 1G). The gene discussed is CD8A; the disease is tuberculosis.